Ovulation Suppression to Prevent Hemoperitoneum and Surgical Menopause in Anticoagulated Women

Brynn S Connor; Elizabeth Coviello; Melissa Fries; Anitha S John

doi:10.1016/j.jaccas.2019.05.014

Ovulation Suppression to Prevent Hemoperitoneum and Surgical Menopause in Anticoagulated Women

JACC Case Rep. 2019 Jun 19;1(1):50-54. doi: 10.1016/j.jaccas.2019.05.014. eCollection 2019 Jun.

Authors

Brynn S Connor¹, Elizabeth Coviello², Melissa Fries², Anitha S John³

Affiliations

¹ Division of Internal Medicine and Pediatrics, Medstar Georgetown University Hospital, Washington, DC.
² Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, MedStar Washington Hospital Center, Washington, DC.
³ Division of Cardiology, Children's National Medical Center and Medstar Washington Hospital Center, Washington, DC.

Abstract

Premenopausal women taking anticoagulation therapy are at risk of developing hemorrhagic ovarian cysts. This paper presents 3 cases of acute hemoperitoneum, with resultant surgical menopause, secondary to cystic hemorrhage in premenopausal women with repaired congenital heart disease (CHD). Adults with CHD taking long-term anticoagulation should be considered candidates for ovulation suppression with hormone-based contraception. (Level of Difficulty: Intermediate.).

Keywords: anticoagulation; congenital heart defect; hemorrhage; hemorrhagic ovarian cysts; ovulatory suppression.

Publication types

Case Reports